Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Patent
1992-02-24
1993-02-16
Higel, Floyd D.
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
536 268, 558180, 558199, 558200, 562 10, C07H 2102, C07H 2104, C07H 1910, C07H 1920
Patent
active
051872668
ABSTRACT:
A compound having the structure: ##STR1## wherein R is CH.sub.3, C.sub.2 H.sub.5, C.sub.3 H.sub.7, t-C.sub.4 H.sub.9 or C.sub.6 H.sub.5 ; R.sup.1 is NH.sub.2, NHCH.sub.3, NHC.sub.2 H.sub.5, NHC.sub.3 H.sub.7, NHC.sub.4 H.sub.9, NHCH.sub.2 CH.sub.2 Cl, NHC.sub.6 H.sub.5, N(CH.sub.3).sub.2, N(C.sub.2 H.sub.5).sub.2, N(C.sub.3 H.sub.7).sub.2, NCH.sub.3 (C.sub.2 H.sub.5), NCH.sub.3 (C.sub.3 H.sub.7), N(CH.sub.2 CH.sub.2 Cl).sub.2, NHOH, NHNHCO.sub.2 CH.sub.2 C.sub.6 H.sub.5, NHNHCO.sub.2 C(CH.sub.3).sub.3, OCH.sub.3, OC.sub.2 H.sub.5, OC.sub.3 H.sub.7, OC.sub.4 H.sub.9, OC.sub.6 H.sub.5, OC.sub.2 C.sub.6 H.sub.5, CH.sub.3, C.sub.2 H.sub.5, C.sub.3 H.sub.7, C.sub.4 H.sub.9, CH.sub.2 NO.sub.2 or CH.sub.2 NH.sub.2 ; and R.sup.2 is NHCH.sub.2 CH.sub.2 Cl or N(CH.sub.2 CH.sub.2 Cl).sub.2.
REFERENCES:
patent: 3852433 (1974-12-01), Tamura
patent: 4211864 (1980-07-01), Vicario et al.
patent: 4271153 (1981-06-01), Gauri
patent: 4297347 (1982-10-01), Katsunuma
patent: 4605645 (1986-08-01), Watanabe et al.
patent: 4697005 (1987-09-01), Swenton et al.
patent: 4797479 (1989-01-01), Shuto et al.
patent: 4816570 (1989-03-01), Farquhar
patent: 4841085 (1989-06-01), Farquhar
patent: 4968788 (1990-11-01), Farquhar
patent: 4973679 (1990-11-01), Caruthers et al.
Sladek, "Bioassay and Relative Cytotoxic Potency of Cyclophosphamide Metabolites Generated in Vitro and in Vivo," Cancer Research, 33:1150-1158, 1973, published in Baltimore, Md.
Connors et al., "Some Studies of the Active Intermediates Formed in the Microsomal Metabolism of Cyclophosphamide and Isophosphamide," Biochemical Pharmacology, 23:115129, 1974, published in Great Britain.
Cox et al., "The Enzymatic Basis of the Selective Action of Cyclophosphamide," Cancer Research, 35:3755-3761, 1975, published in Baltimore, Md.
Friedman et al., "Cyclophosphamide and Related Phosphoramide Mustards," Advances in Cancer Chemotherapy, Andre Rosowvsky, Ed., pp. 143-204, 1979, published in New York.
Sharkis et al., "Elimination of Acute Myelogenous Leukemic Cells from Marrow and Tumor Suspensions in the Rat with 4-Hydroperoxycyclophosphamide," Blood, 55(3):521-523, 1980, published in Philadelphia, Pa.
Kobling et al., "4-Hydroperoxycyclophosphamide: A Model for Eliminating Residual Human Tumour Cells and T-lymphocytes from the Bone Marrow Graft," British Journal of Haematology, 52:89-96, 1982, published in Great Britain.
Hilton & Colvin, "The Role of Aldehyde Dehydrogenase (AHD) Activity in Cyclophosphamide Sensitivity of Hematopoietic and Leukemic Cell Populations," Proc. Amer. Assoc. Cancer Res., #1343, p. 339, 1984, published in U.S.A.
Hilton, "Deoxyribonucleic Acid Crosslinking by 4-Hydroperoxycyclophosphamide in Cyclophosphamide-Sensitive and -Resistant L1210 Cells," Biochemical Pharmacology, 33(12):1867-1872, 1984, published in Great Britain.
Hilton, "Role of Aldehyde Dehydrogenase in Cyclophosphamide-Resistant L1210 Leukemia," Cancer Research, 44:5156-5160, 1984, published in Baltimore, Md.
Sladek & Landkamer, "Restoration of Sensitivity to Oxazaphosphorines by Inhibitors of Aldehyde Deydrogenase Activity in Cultured Oxazaphosphorine-Resistant L1210 Cross-Linking Agent-Resistant P388 Cell Lines," Cancer Research, 45:1549-1555, 1985, published in Baltimore, Md.
Stewart et al., "Autologous Marrow Transplantation in Patients with Acute Nonlymphocytic Leukemia in First Remission," Experimental Hematology, 13:267.sub.]272, 1985, published in New York.
Struck et al., "Isolation and Mass Spectral Identification of Blood Metabolites of Cyclophosphamide: Evidence for Phosphoramide Mustard as the Biologically Active Metabolite," Journal, volume number and place of publication unknown, pp. 46-52, 1975.
Norpoth, "Studies on the Metabolism of Isophosphaide (NSC-109724) in Man," Cancer Treatment Reports, 60(4):437-443, 1976, published in Bethesday, Md.
Peter et al., "Studies on 4-Hydroperoxycyclophosphamide (NSC-181815): A Simple Preparation Method and its Application for the Synthesis of a New Class of Activated sulfur-Containing Cyclophosphamide (NSC-26271) Derivatives", Cancer Treatment Reports, 60(4):429-435, 1976, published in Bethesda, Md.
Struck, "Aldophosphamide: Synthesis, Characterization, and Comparison with `Hohorst's Aldophosphamide`," Cancer Treatment Reports, 60(4):317-319, 1976, published in Bethesda, Md.
Frei et al., "New Approaches to the Treatment of Non-Hodgkin's Lymphoma," Cancer Treatment Reports, 61(6):1209-1217, 1977, published in Bethesda, Md.
Farquhar et al., "An Efficient and Convenient Synthesis of 5-(3,3-Dimethyl-.sup.14 C-1-Triazeno)-Imidazole-4-Carboxamide," Journal of Labelled Compounds and Radiopharmaceuticals, 16(4):615-621, 1979, published in England.
Farquhar et al., "Syntheses of .sup.14 C-Mustard-Labelled and .sup.14 C-Leucine-Labelled Asaley," Journal of Labelled Compounds and Radiopharmaceuticals, 17(2):159-169, 1980, published in England.
Zon et al., "O-Methylhydroxylamine as a New Trapping Reagent for Quantitative Studies of 4-Hydroxycyclophosphamide and Aldophosphamide," Journal of Pharmaceutical Sciences, 71(4):443-446, 1982, published in Washington, D.C.
Farquhar et al., "Synthesis and Biological Evaluation of Neutral Derivatives of 5-Fluoro-2'-deoxyuridine 5'-Phosphate," J. Med. Chem., 26:1153-1158, 1983, published in Washington, D.C.
Farquhar et al., "Biologically Reversible Phosphate-Protective Groups," Journal of Phamaceutical Sciences, 72(3):324-325, 1983, published in Washington, D.C.
Garattini, "Importance of Establishing the Presence of Drug Active Metabolites," European Journal of Drug Metabolism and Phamacokinetics, 8(2):97-108, 1983, published in Europe.
Struck et al., "Isophosphoramide Mustard, a Metabolite of Ifosfamide with Activity Against Murine Tumours Comparable to Cyclophosphamide," British Journal of Cancer, 47:15 & 18, 1983, published in Great Britain.
Herve et al., "Autologous Bone Marrow Transplantation for Acute Leukemia Using Transplant Chemopurified with metabolite of Oxazaphosphorines (ASTA Z 7557, INN Mafosfamide)," Investigational New Drugs, 2:245-252, 1984, published in The Netherlands.
Struck & Alberts, "Blood Levels of Alkylating Metabolites of Cyclophosphamide in the Mouse after IV or Oral Administration," Cancer Treatment Reports, 68(5):765-767, 1984, published in Bethesda, Md.
de Jong et al., "Comparative in Vitro Effects of Cyclophosphamide Derivatives on Murine Bone Marrow-Derived Stromal and Hemopoietic Progenitor Cell Classes," Cancer Research, 45:4001-4005, 1985, published in Baltimore, Md.
Gordon et al., "4-Hydroperoxycyclophosphamide Inhibits Proliferation by Human Granulocyte-Macrophage Colony-Forming Cells (GM-CFC) But Spares More Primitive Progenitor Cells," Leukemia Research, 9(8):1017-1021, 1985, published in Great Britain.
Kohn & Sladek, "Aldehyde Dehydrogenase Activity as the Basis for the Relative Insensitivity of Murine Pluripotent Hematopoietic Stem Cells to Oxazaphosphorines," Biochemical Pharmacology, 34(19):3465-3471, 1985, published in Great Britain.
Smith & Sladek, "Sensitivity of Murine B- and T-Lymphocytes to Oxazaphosphorine and Non-Oxazaphosphorine and Nitrogen Mustards," Biochemical Pharmacology, 34(19):3459-3463, 1985, published in Great Britain.
Yeager et al., "Autologous Bone Marrow Transplantation in Patients with Acute Nonlymphocytic Leukemia, Using Ex Vivo Marrow Treatment with 4-Hydroperoxycyclophosphamide," The New England Journal of Medicine, 315(3):141-147, 1986, published in U.S.A.
Kohn et al., "Effect of Aldehyde Dehydrogenase Inhibitors on the ex Vivo Sensitivity of Human Multipotent and Committed Hematopoietic progenitor Cells and Malignant Blood Cells to Oxazaphosphorines," Cancer Research, 47:3180-3185, 1987, published in Baltimore, Md.
Montgomery & Struck, "Synthesis and Structure-Activity Relationships of Pre-Activated Analogs of Cyclophosphamide (NSC-26271)," Cancer Treatment Reports, 60(4):381-393, 1976, published in Bethesda, Md.
Struck, "Isolation and Identification of a Stabilized Derivative of Aldophosphamide, a Major Metabolite of Cyclophosphamide," Cancer Research, 34:2933-2935, 1974, published in Baltimore, Md.
(Previously desig
Farquhar David
Wang Yugiang
Board of Regents , The University of Texas System
Higel Floyd D.
LandOfFree
Antitumor aldophosphamide glycoside and dideoxyuridine derivativ does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antitumor aldophosphamide glycoside and dideoxyuridine derivativ, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antitumor aldophosphamide glycoside and dideoxyuridine derivativ will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2148799